Hedge Funds Are Piling Into Lyra Therapeutics, Inc. (LYRA)
In this article you are going to find out whether hedge funds think Lyra Therapeutics, Inc. (NASDAQ:LYRA) is a good investment right now.
Lyra Therapeutics Inc. (LYRA)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 3,222,560 | $29,403 | 0.42% | |
| 2. | Pura Vida Investments Efrem Kamen | 533,417 | $4,867 | -2% | 0.15% |
| 3. | Ikarian Capital Neil Shahrestani | 403,450 | $3,688 | -36% | 0.25% |
| 4. | Soleus Capital Guy Levy | 215,576 | $1,967 | +18% | 0.3% |
| 5. | Parian Global Management Zachary Miller | 121,300 | $1,109 | 0.77% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.97 | 3,500 | Director | 3,500 | 2021-06-17 | Filing | |
| $9.72 | 1,025 | Director | 1,025 | 2020-12-16 | Filing | |
| $16.00 | 625,000 | Large Shareholder, Director | 1,934,115 | 2020-05-05 | Filing | |
| $16.00 | 155,000 | Large Shareholder | 155,000 | 2020-05-05 | Filing | |
| $16.00 | 75,000 | Large Shareholder | 553,123 | 2020-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 16,909 | Large Shareholder | 457,421 | 2020-05-05 | Filing | |
| $16.00 | 7,255 | Large Shareholder | 478,123 | 2020-05-05 | Filing | |
| $16.00 | 5,568 | Large Shareholder | 324,057 | 2020-05-05 | Filing | |
| $16.00 | 11,360 | Large Shareholder | 661,153 | 2020-05-05 | Filing | |
| $16.00 | 7,255 | Large Shareholder, Director | 478,123 | 2020-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,100,852 | $10,044 | 71.28% | |
| 2. | 220,029 | $2,008 | 0% | |
| 3. | 200 | $1,825 | 0% | |
| 4. | 139,187 | $1,272 | 0% | |
| 5. | 110,511 | $1,008 | 0% |
News See All
10 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital
In this article, we will take a look at the 10 stocks to buy according to Neil Shahrestani's Ikarian Capital.
Should I Avoid Lyra Therapeutics, Inc. (LYRA)?
In this article we will take a look at whether hedge funds think Lyra Therapeutics, Inc. (NASDAQ:LYRA) is a good investment right now.
Is Lyra Therapeutics, Inc. (LYRA) A Good Stock To Buy?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
